Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Genomics Personalized Health Market Value Analysis: What Growth Is Expected Over The Forecast Period?
The genomics personalized health market size has witnessed rapid expansion in recent years. It is anticipated to expand from $18.5 billion in 2025 to $21.46 billion in 2026, achieving a compound annual growth rate (CAGR) of 16.0%. This historical growth can be attributed to progress in sequencing technologies, decreasing costs of genomic testing, the expansion of clinical genomics research, the development of personalized medicine initiatives, and greater availability of bioinformatics tools.
The genomics personalized health market is projected to experience swift expansion over the coming years. This market is forecast to reach $36.55 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 14.2%. This anticipated growth during the forecast period stems from factors such as the greater uptake of population-level genomics initiatives, increased capital directed towards AI-powered diagnostics, the broadening scope of individualized treatments, the deepening incorporation of genomics into standard clinical practices, and a sharpened emphasis on healthcare models focused on prediction. Key trends anticipated within this period involve the wider acceptance of genomic data analytics platforms, an uptick in AI applications for interpreting genetic variants, the proliferation of tailored treatment routes, the increasing fusion of genomics with preventive health strategies, and a heightened commitment to precise diagnostic methods.
Download A Free Sample Report For Comprehensive Market Insights:
Genomics Personalized Health Market Expansion Drivers: What Is Shaping Future Growth?
The increasing demand for personalized medicine is projected to stimulate the growth of the genomics personalized health market. Personalized medicine, also referred to as precision medicine, represents a healthcare methodology that adapts medical treatments and practices to the unique characteristics of each patient. This heightened demand for personalized medicine arises from a transition towards preventive healthcare, enhanced treatment outcomes, greater patient empowerment and engagement, economic advantages, and the rising prevalence of chronic and complex diseases. Genomics personalized health plays a crucial role in advancing personalized medicine by utilizing individual genetic information to customize medical care, encompassing prevention, diagnosis, treatment, and monitoring. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit, stated that the Food and Drug Administration (FDA) approved 16 novel personalized therapies for patients with rare diseases in 2023, a significant increase from six in 2022. Hence, the growing need for personalized medicine is a key driver for the genomics personalized health market.
Genomics Personalized Health Market Segment Breakdown: Which Categories Generate The Most Revenue?
The genomics personalized health market covered in this report is segmented –
1) By Test Type: Oncology Testing, Infectious Disease Testing, Orphan Disease Testing, Autoimmune Disease Testing, Obstetrics Testing
2) By Technology: NGS Platforms, Microarray, Genetic Analyzers
3) By End User: Academic Research Institutes, Diagnostic Centers, Other End Users
Subsegments:
1) By Oncology Testing: Cancer Genomic Profiling, Liquid Biopsy Testing, Tumor Mutational Burden Testing, Genetic Biomarker Testing
2) By Infectious Disease Testing: Next-Generation Sequencing (NGS) Tests, Microbial Genomic Profiling
3) By Orphan Disease Testing: Genetic Screening For Rare Diseases, Genetic Testing For Inherited Disorders, Targeted Gene Panels
4) By Autoimmune Disease Testing: Genetic Screening For Autoimmune Conditions, Immune System Gene Profiling, HLA Typing Tests
5) By Obstetrics Testing: Non-Invasive Prenatal Testing (NIPT), Genetic Screening For Birth Defects, Carrier Screening Tests
Genomics Personalized Health Market Trends Reshaping Industry Growth
Leading firms within the genomics personalized health market are concentrating on creating inventive offerings, including cloud-based software intended for the tertiary analysis of clinical next-generation sequencing (NGS) data, to secure a competitive advantage. Clinical next-generation sequencing (NGS) data represents genetic information produced by sequencing technologies, enabling comprehensive, high-throughput examination of DNA or RNA samples within a clinical environment. As an illustration, in March 2023, Illumina, a US-based biotechnology firm renowned for DNA sequencing and array-based technologies, introduced Connected Insights, a cloud-based software engineered for the tertiary analysis of clinical next-generation sequencing (NGS) data. This platform aims to simplify interpretation and reporting workflows, particularly for oncology applications, and facilitates comprehensive genomic profiling. Connected Insights incorporates diverse third-party knowledge bases, thereby supporting accurate data analysis and boosting the effectiveness of precision care initiatives.
Genomics Personalized Health Market Key Players And Strategic Industry Positioning
Major companies operating in the genomics personalized health market are Illumina Inc., Quest Diagnostics, Exact Sciences Corporation, Natera Inc., Adaptive Biotechnologies Corporation, Myriad Genetics Inc., Pacific Biosciences of California Inc., Personalis Inc., Invitae Corporation, GRAIL Inc., XCode Life Sciences Private Limited, BGI Genomics Co. Ltd., Genetic Technologies Limited, Eastern Biotech and Life Sciences, Tempus AI, Guardant Health, Freenome, Color Genomics, Helix, NantOmics, Novogenia GmbH, Clear Labs
Access The Complete Genomics Personalized Health Market Report:
Genomics Personalized Health Market Largest Region By Revenue And Market Share
North America was the largest region in the personalized health market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genomics personalized health market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.